Sol-Gel Technologies Ltd.
-
Ticker
SLGL
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Ness Ziona, Israel
Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing and commercializing topical dermatological drug products. Their lead product candidates, VERED for the treatment of papulopustular rosacea and TWIN and SIRS-T for the treatment of acne vulgaris (“acne”) are based upon their proprietary microencapsulation delivery system. This technology consists of microcapsules
…More made of silica. Based on their pre-clinical and clinical data, this delivery system should enable them to develop and commercialize dermatological drug products that are more effective and/or have fewer side effects than currently marketed drugs.
REPORT RATINGS
4.8 / 5.0 (76)
Sol-Gel Technologies Ltd. reports have an aggregate usefulness score of 4.8 based on 76 reviews.
Sol-Gel Technologies Ltd.
Most Recent Annual Report
MOST RECENT
2023 Annual Report
Older/Archived Annual Reports